Disease-modifying therapies for type 1 diabetes are beginning to move care beyond insulin replacement by targeting immune ...

Researchers at Stanford Medicine have reported a breakthrough in Type 1 diabetes research after successfully curing the ...

Millions of Americans are living with Type 1 diabetes -- a chronic auto-immune disorder that requires daily injections and constant monitoring, but a clinical trial is looking to change the game ...

PSC-derived cells can reverse type 1 diabetes in mice and may overcome some of the hurdles faced by existing stem cell ...

With better screening for type 1 diabetes and a new treatment called TZield, the outlook is improving for people with the ...

Bayer announced today that the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) and granted Priority Review designation for KERENDIA ® (finerenone), which ...

In the FINE-ONE trial, finerenone met its primary endpoint by significantly reducing the urinary albumin-to-creatinine ratio by 25% compared with placebo over 6 months in adults with T1D and CKD. The ...

Researchers from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have reached a significant advance in ...

Each November, we observe National Diabetes Month and engage in discussions surrounding prevention, management and the impact of this increasingly common autoimmune disease. Diabetes, both type 1 and ...

Identifying children with early signs of type 1 diabetes makes a difference to their health. A new study suggests wider ...